ALK CEO to step down, replacement found at Fertin Pharma
After nearly seven years, Carsten Hellmann and ALK are parting ways at the latest at the end of 2023. (Updated)
By Christian Bundgaard, translated by Daniel Pedersen
After nearly seven years leading ALK, Carsten Hellmann and the Danish allergy company’s board of directors have come to a mutual agreement that means Hellmann will step down as chief executive officer at the end of 2023.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
.jpg&w=384&q=75)
